Stock listing

Guardant Health, Inc.

Selected listing: A2N5RY · LS · EUR · DE

Guardant Health, Inc. (Lang & Schwarz: A2N5RY), Health Technology. Latest release Oct 5, 2026: Guardant Health COSMOS Study Published in Cancer Research…

A2N5RY:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A2N5RY
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Guardant Health, Inc.

Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma

October 5, 2026

Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma

October 4, 2026

Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening

September 14, 2026

Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer

September 9, 2026

Business Insider Names Guardant Health One of America's Most Innovative Businesses

September 8, 2026

All Guardant Health, Inc. news →

Events

Replays

Guardant Health, Inc. (GH) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
Guardant Health, Inc. (GH) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Guardant Health, Inc. (GH) Q3 2025 Earnings Call
Wed, Oct 29, 2025 · 04:30 PM ET
Watch

Research Guardant Health, Inc.

Guardant Health, Inc. company profile

View the public company page for Guardant Health, Inc. on 6ix.

Guardant Health, Inc. news

Read company news and market updates connected to Guardant Health, Inc..

Guardant Health, Inc. investor events

Find investor webinars, events, and replay context for Guardant Health, Inc..